leisure time -WSS

leisure time

author：entertainment 2025-09-06 05:54:06 - browse：37

WICHITA, Kan. -- A second suspect is now in custody in connection with a mass shooting that injured nearly a dozen people earlier this month in Kansas, Wichita police announced Monday.

A 27-year-old man was arrested on suspicion of aggravated battery and possession of a firearm by a felon. On Friday, a 19-year-old man was arrested. It wasn't immediately clear if either man has been charged. Their names have not been released. A message left with Sedgwick County District Attorney Marc Bennett wasn't immediately returned.

The shooting happened in the early hours of July 2 at City Nightz in downtown Wichita. Nine people were shot and two others were trampled in the chaos that followed. No one died.

In addition to the arrests, police are searching for a 23-year-old man believed to have been involved in the shooting. A St. Louis-area man was arrested July 3, but prosecutors later determined he fired his gun to defend himself after shots were fired by two other men at the club.

The gunshot victims — seven men and two women — ranged in age from 22 to 34, police said. The two people trampled were a 30-year-old woman and a 31-year-old male.

Wichita is a city of nearly 400,000 people, located about 200 miles (320 kilometers) southwest of Kansas City, Missouri.

Previous article： Drug repurposing or repositioning? The language matters
Next article： 3 questions for the future of Biden's cancer moonshot

focus

WSS

AI can decode, harness the power of the humane immune system

Stroke deaths set to near 10 million globally by 2050

Wildfire pollution widens asthma inequities on Long Island

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

National panel will explore requiring free Covid tests

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

hotspot

leisure time

focus

Malaria cases in Florida and Texas: Here’s what you need to know

What to expect at HLTH 2023, the health care industry conference

Bright Health sells Medicare Advantage business to Molina

Why Charlie Gard's case is so disturbing to Americans

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Infectious disease expert Jeanne Marrazzo assumes Fauci role

How to save PrEP access — and even expand it

Readout Newsletter: Biotech news, including Moderna's Covid vaccine

Hollywood unions extend contract negotiations for actors

Histogen: Failed biotech offers rare public look inside

knowledge

FDA panel signals lack of confidence in Amgen cancer drug data

What the airline industry can learn from medicine

FDA rejects Alnylam's heart disease treatment over insufficient data

Phenylephrine and the overlooked value of the placebo effect

What the US credit downgrade means for the economy, your finances

EQRx, failed developer of low

explore

focus

focus

leisure time